New study demonstrates advances in creating treatment for common childhood blood cancer
- OPACC
- Oct 20, 2014
- 1 min read
Researchers at NYU Langone Medical Center conclude new drug in development may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia.
Comments